Potential Biomarker for Multiple Sclerosis
In a study titled “Adipsin is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines,” researchers report a correlation between an adipokine called adipsin and the pathogenesis of multiple sclerosis (MS). The study was published in the Multiple Sclerosis International journal.
The findings support a role for adipsin in MS and suggest that adipsin may carry a predictive value and be potentially used as a biomarker of neurodegeneration.
Read more about adipsin as a biomarker for MS here: http://bit.ly/1o2VgcQ